Malaysia approves China’s Sinopharm, J&J Covid-19 vaccines for emergency use

Health director-general Tan Sri Dr Noor Hisham Abdullah said the government has also granted conditional approval to the Janssen Covid-19 vaccine made by US drugmaker Johnson & Johnson and manufactured in Belgium. — Picture by Hari Anggara
Health director-general Tan Sri Dr Noor Hisham Abdullah said the government has also granted conditional approval to the Janssen Covid-19 vaccine made by US drugmaker Johnson & Johnson and manufactured in Belgium. — Picture by Hari Anggara

Follow us on Instagram and subscribe to our Telegram channel for the latest updates.


KUALA LUMPUR, July 16 — Malaysia’s Health Ministry said today it has granted conditional approval for emergency use to the Covid-19 vaccine manufactured by China’s Sinopharm.

The Sinopharm vaccine in Malaysia was registered by pharmaceutical company Duopharma Sdn Bhd, Health director-general Tan Sri Dr Noor Hisham Abdullah said in a statement.

Duopharma had previously announced a deal to supply the Malaysian government with 6.4 million doses of the Russian-made Sputnik V vaccine.

The company did not immediately respond to a request for comment on the Health Ministry’s announcement on Sinopharm.

Authorities have also granted conditional approval to the Janssen Covid-19 vaccine made by US drugmaker Johnson & Johnson and manufactured in Belgium, Dr Noor Hisham said.

Malaysia had earlier approved another batch of Janssen vaccines that had been given the greenlight for emergency use by the World Health Organisation. — Reuters

You May Also Like

Related Articles